Kunena :: Тема: Posted by Gore Janis on 29.11.2016 16:37:18: erlotinib licence (1/2)

Навигация: Главная Форум Главный раздел Сообщество базовых площадокPosted by Gore Janis on 29.11.2016 16:37:18: erlotinib licence

Добро пожаловать, Гость

Форум

Главный раздел

Сообщество базовых площадок

Posted by Gore Janis on 29.11.2016 16:37:18: erlotinib licence

Страница:
1
2

ТЕМА: Posted by Gore Janis on 29.11.2016 16:37:18: erlotinib licence

Posted by Gore Janis on 29.11.2016 16:37:18: erlotinib licence 7 года 5 мес. назад #921

akipk

High Quality - Low Cost Anti-Cancer Drugs

*
Genentech Access Solutions offers coverage support, patient assistance, other useful information needed for Tarceva.
Ik slik nu 10 maanden Tarceva om mijn longkanker te remmen en dit werkt erg goed. Wel is er uitgebreid onderzoek aan vooraf gegaan om zeker te weten dat mijn soort longkanker geschikt is voor dit medicijn. De bijwerkingen zijn minimaal. In het begin had ik veel huiduitslag op mijn hoofd en boven lichaam maar met een anti biotica (minocyline 100) is dit goed onder control [lees meer. ] e. Verder heb ik last van wat hoesten maar dit is wel te doen. Ik gebruik een aantal natuurlijke voedingssuppementen ter verdere ondersteuning, Ik ben erg benieuwd naar ervaringen van andere Tarceva gebruikers. Het middel is nu drie jaar op de markt en er is nog weinig bekend over de effecten op de wat langere termijn. Ik slik nu 10 maanden Tarceva om mijn longkanker te remmen en dit werkt erg goed. Wel is er uitgebreid onderzoek aan vooraf gegaan om zeker te weten dat mijn soort longkanker geschikt is voor dit medicijn. De bijwerkingen zijn minimaal. In het begin had ik veel huiduitslag op mijn hoofd en boven lichaam maar met een anti biotica (minocyline 100) is dit goed onder controle. Verder heb ik last van wat hoesten maar dit is wel te doen. Ik gebruik een aantal natuurlijke voedingssuppementen ter verdere ondersteuning, Ik ben erg benieuwd naar ervaringen van andere Tarceva gebruikers. Het middel is nu drie jaar op de markt en er is nog weinig bekend over de effecten op de wat langere termijn.
Buonasera Dottore, grazie per la pazienza e la dovizia. Purtroppo i sintomi non regrediscono, stanchezza costante che non permette una deambulazione regolare nonchè una sorta di stato veriginoso. Ora le patologie cerabrali sono state escluse dopo RMN e i medici propendeno per una progressione della malattia polmonare. Inoltre emerge anche uno stato di disattenzione e mancanza di memoria. Gradirei sapere cosa ne pensa. La terapia con Tarceva quali benefici potrà dare a livello di qualità della vita. Grazie
gorodznaniy.com/index.php/forum/dobro-po...n-reaction-treatment
In lung cancer, there are assays for quantitative testing of epidermal growth factor receptors (EGFR), which confers sensitivity to some drugs used in lung cancer like Iressa or Tarceva. The cost of testing can range from a few hundred dollars (e.g. ER/ PR assays) to around 3800 dollars for the Oncotype DX test.
Effect of epidermal growth factor receptor status on treatment effect in other trials. EGFR status measured by immunohistochemistry was not a predictor of tumor response in previous lung cancer clinical trials with erlotinib or gefitinib, a related EGFR tyrosine kinase inhibitor. Two single-arm gefitinib trials comparing 250 and 500 mg daily (6 ) and one single-arm erlotinib trial of 150 mg daily (7 ) assessed the relationship of tumor membrane EGFR staining and tumor response in patients with NSCLC treated with gefitinib or erlotinib as second-line or third-line chemotherapy. These trials did not show a relationship between EGRF expression and tumor response. The present study is the only one where EGRF status measured by immunohistochemistry has been assessed to determine if it predicts for treatment effect on survival.
Hi, I'm from the Philippines. My mom has stage III lung cancer and is presently taking Erlotinib (Tarceva) which is an oral form of chemotherapy for a. show more Hi, I'm from the Philippines. My mom has stage III lung cancer and is presently taking Erlotinib (Tarceva) which is an oral form of chemotherapy for a month now. It is very expensive and we could not really afford to buy the drug again in the usual way ( from the pharmacy/pharmaceutical company). I would like to know if there is someone out there who has Tarceva but doesn't need or is not taking it anymore and is willing to sell it to us at a much lower price. Please.
RADIANT, a phase 3 trial (see Table 4 ), is expected to test erlotinib as a maintenance therapy following surgery and chemotherapy (if used) in patients with EGFR -positive, early-stage NSCLC, as determined by FISH or IHC analysis. 55
www.profavtodor02.ru/index.php/forum/dob...tarceva-in-australia
2 Responses to RADIANT and SELECT: Is Adjuvant Erlotinib Effective in Early-Stage Lung Cancer?
we are a specialist in anti-cancer medicines like veenat, geftinat, erlonat, sorfanet, afnitor, evertor. acetate ,crizilak and many more.
The double mutant (H1975) showed no uptake in the tumor upon P-gp inhibition for [ 11 C]erlotinib (Table 1. entry

similar to the unblocked situation (Table 1. entry 2). For [ 18 F]afatinib, a higher activity concentration was observed (Figure 5 ), although the tumor-to-background ratio remained similar to the non-blocked situation (Table 1. entries 5 and 11).
38 de La Motte Rouge T. Galluzzi L. Olaussen KA et al . A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib. Cancer Res 2007 ; 67. 6253 – 62.
Anti Cancer drugs ERLONAT 150mg Tablets
bowlangarsk.ru/forum/otchety-i-obsuzhden...-apteka-tarceva-cena
The median follow-up for all patients was 11 months (range, 3-20 months), and the median follow-up for surviving patients was 16 months (range, 8-20 months). Twelve of 14 patients were able to complete their prescribed dose of radiation with no or minimal treatment delay. One patient at Dose Level 1 had no response to treatment and was switched to an alternative regimen, which consisted of 5-fluorouracil, hydroxyurea, and accelerated radiation. A second patient at Dose Level 2 discontinued reirradiation at a dose of 24.2 Gy because of inability to tolerate treatment related to positional discomfort and anxiety that was refractory to medications. Overall, 94% of the prescribed radiation dose was delivered. However, mainly because of patient refusal, only 3 of 14 patients received maintenance erlotinib.
ufbk.ru/forum?view=topic&catid=12&id=11529
We also sequenced endogenous Kras from cDNA generated from 21 tumors that were harvested from mice that underwent multiple rounds of erlotinib treatment, to test whether mutations in this gene were associated with drug resistance. We detected a guanine (G)-to-thymine (T) transversion leading to a G12V amino acid substitution in one of these tumors (4.7%; K6944, tumor 1) (Table 1 ). Lung tumors bearing Kras mutations can occur spontaneously in aging mice with variable frequencies depending on the mouse strain (Dragani et al. 1995 ). This tumor did not respond to erlotinib treatment (it appeared to decrease by 6% in the first round of treatment and to increase by 2% in the final round of treatment) (see supplementary material Table 1 ), strongly indicating that it was a Kras -driven tumor, unrelated to the expression of mutant EGFR . Of note, KRAS mutations have been implicated as a mechanism of primary resistance but not acquired resistance to TKIs in humans (Pao et al. 2005a ; Pao et al. 2005b ). No Kras mutations were detected in cDNA derived from matched normal lung or from ten tumors from untreated mice (Table 1 ).
Mauer AM, Cohen EEW, Wong SJ et al. Phase I study of epidermal growth factor receptor (EGFR) inhibitor, erlotinib, and vascular endothelial growth factor monoclonal antibody, bevacizumab, in recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). Proc Am Soc Clin Oncol 2004 ; 23. 5539.
Hi, Just wondering if anyone has gone throught the process of trying to get Tarceva in Canada. Our Oncologist wrote to the ministry of Health stating that the 1st line had failed and he is reccommending Tarceva. He said the wait for a response could be 2-4 weeks. Is this the normal procedure in Canada? Thanks, Joey
Levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) during erlotinib therapy and subsequent gefitinib therapy in a 31-year-old Japanese woman with non-small cell lung cancer (NSCLC) .
Yamamoto N. Kaira K. Naito T. Takahashi T. Ayabe E. Shimoyama R. et al. (2010) Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung cancer. Lung Cancer 68. 99–104 [PubMed ]
Table 3: NSCLC 2 nd/3 rd Line Study: Selected Adverse Reactions Occurring with an Incidence Rate ≥ 10% and an Increase of ≥ 5% in the Single-Agent Tarceva Group compared to the Placebo Group (Study 1)
Clark GM, Perez-Soler R, Sui L, Gordon A, Santabárbara P (2003) Rash severity is predictive of increased survival with erlotinib HCl. Proc Am Soc Clin Oncol 22. Abstract 786.
therealsecretswomenonlywhisper.com/profi...10-29-56-tarceva-all
Erlotinib and Gefitinib slow the growth of cancer by interrupting the signals between mutated cells without harming healthy cells.
No prior anti-cancer EGFR therapy (e.g. erlotinib, gefitinib, or cetuximab)
In cell lines derived from a variety of tissue types (non-small-cell lung, pancreatic, colon, and breast), combination of Erlotinib HCl and Rapamycin results in a synergistic inhibition effect on cell growth by inhibition of both S6 and Akt. In a Calu6 xenograft model, Rapamycin and Erlotinib HCl combination shows synergistic effects in inhibiting tumor growth. [6]
Drug: Patritumab Drug: erlotinib: Drug: Placebo
domkolbaski.ru/forum/3--/80918-posted-by...-tarceva-150-mg.html
This study examined care consumption and management costs among patients who received second- or third-line oral erlotinib therapy for non small-cell lung cancer (NSCLC).
gamebite.ru/kunena/razdel-predlozhenij/1...tarceva-alternatives
TARCEVA 25MG 30 FILM TAB.
I believe that we are spiritual beings having a human experience so death is just the beginning of a new journey but to us survivors it is a huge loss and creates a huge void that is difficult to fill so we are the ones that suffer while the deceased continues on their journey. Well I had better end here and I will continue to pray for your mom as How I would love to see someone from this board with advanced lung cancer win the battle even if it is not my own mom. Maybe my mom went through all of this to show how they are on the right path with drugs like Tarceva and someday chemo will not be necessary. Who's to say why anyone is put through this hell? JanMarie
In an open-label, multicenter trial, 25 pediatric patients (median age 14 years, range 3-20 years) with recurrent or refractory ependymoma were randomized (1:1) to TARCEVA or etoposide. Thirteen patients received TARCEVA at a dose of 85 mg/m²/day orally until disease progression, death, patient request, investigator decision to discontinue study drug, or intolerable toxicity. Four patients randomized to etoposide also received TARCEVA following disease progression. The trial was terminated prematurely for lack of efficacy; there were no objective responses observed in these 17 TARCEVA-treated patients.
The dangerous drug attorneys at the Law Offices of Gregory Krasovsky can provide legal support and representation to any plaintiff seeking to pursue a legitimate Tarceva lawsuit. In order to take on big pharmaceutical companies, it is crucial to have a competent Tarceva lawyer. Contact a Tarceva attorney at the Law Offices of Gregory Krasovsky today to take the first step in securing a just Tarceva settlement.
Verträglichkeit der höheren Erlotinib-Dosis
In closing, we also acknowledge that, in addition to the researchers and medical professionals who have contributed to the clinical success of Tarceva, none of our achievements would have been possible without the selfless contributions of the patients and their families who have participated, and continue to participate, in the many clinical trials we conduct each year aimed at improving the health of cancer and diabetes patients around the world.